See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $805B | 13.4x | 30.8x | |
| $482B | 5.2x | 13.8x | |
| $449B | 7.5x | 17.4x | |
| $284B | 3.7x | 9.4x | |
| $280B | 4.8x | 13.9x | |
| $259B | 4.7x | 11.4x | |
| $242B | 3.7x | 8.2x | |
| $230B | 4.8x | 9.9x | |
| $208B | 5.9x | 11.5x | |
| $188B | 3.0x | 7.6x | |
| $169B | 5.8x | 11.1x | |
| $132B | 2.5x | 8.5x | |
| $128B | 2.7x | 7.8x | |
| $113B | 2.7x | 7.9x | |
| $104B | 8.8x | 22.3x | |
| $69.6B | 8.7x | 17.1x | |
| $69.2B | 7.3x | 16.9x | |
| $68.5B | 1.3x | 6.2x | |
| $68.0B | 2.3x | 8.6x | |
| $66.3B | 2.7x | 9.4x | |
| $65.0B | 4.1x | 12.2x | |
| $53.6B | 11.7x | 39.7x | |
| $53.6B | 11.7x | 39.7x | |
| $51.5B | 5.6x | 19.1x | |
| $43.4B | 7.0x | 24.6x | |
| $41.6B | 3.2x | 15.3x | |
| $39.1B | 2.3x | 7.9x | |
| $33.9B | 3.0x | 14.3x | |
| $28.6B | 10.0x | 28.7x | |
| $26.8B | 1.7x | 7.2x | |
| $25.9B | 1.8x | 6.2x | |
| $24.8B | 2.5x | 7.9x | |
| $23.6B | 11.8x | 31.7x | |
| $22.7B | 7.8x | 8.2x | |
| $22.2B | 2.2x | 6.3x | |
| $21.8B | 57.2x | 626.7x | |
| $21.7B | 1.7x | 7.9x | |
| $19.2B | 127.3x | 229.2x | |
| $19.0B | 10.7x | 84.7x | |
| $17.5B | 2.0x | 8.3x | |
| $15.3B | 3.4x | 12.6x | |
| $14.8B | 4.1x | 11.0x | |
| $14.7B | 4.9x | 13.0x | |
| $14.1B | 10.1x | 30.8x | |
| $13.7B | 30.2x | -866.8x | |
| $13.6B | 4.9x | 20.3x | |
| $13.6B | 2.3x | 13.4x | |
| $13.6B | 4.5x | 11.8x | |
| $12.9B | 47.2x | -290.6x | |
| $12.6B | 3.9x | 16.0x | |
| $12.3B | 2.1x | 14.6x | |
| $11.9B | 0.3x | 5.4x | |
| $11.9B | 7.7x | 30.2x | |
| $11.2B | 14.0x | 44.7x | |
| $11.1B | 2.9x | 11.8x | |
| $11.0B | 2.6x | 6.9x | |
| $10.9B | n/a | n/a | |
| $10.6B | 3.4x | 8.6x | |
| $10.6B | 3.9x | 13.6x | |
| $10.5B | 3.8x | 15.7x | |
| $10.3B | 3.1x | 7.7x | |
| $10.0B | 1.6x | 5.2x | |
| $10.0B | 2.5x | 9.1x | |
| $10.0B | 1.6x | 12.8x | |
| $9.9B | 4.7x | 12.7x | |
| $9.3B | n/a | n/a | |
| $9.0B | 3.8x | 6.5x | |
| $8.7B | 6.8x | 10.5x | |
| $8.6B | n/a | n/a | |
| $8.2B | 812.7x | -39.2x | |
| $8.1B | 1.6x | 12.4x | |
| $7.6B | 2.1x | 10.0x | |
| $7.5B | 19.7x | -454.9x | |
| $7.3B | 4.7x | 23.8x | |
| $7.2B | 3.9x | 18.4x | |
| $6.7B | 2.0x | 7.7x | |
| $6.6B | 8.7x | 32.5x | |
| $6.6B | 2.1x | 9.3x | |
| $6.4B | 5.6x | 19.0x | |
| $6.4B | 2.8x | 7.7x | |
| $6.3B | 1.5x | 8.3x | |
| $6.3B | 16.6x | 24.9x | |
| $6.2B | 4.0x | 50.2x | |
| $6.1B | 3.8x | 20.0x | |
| $6.1B | n/a | n/a | |
| $5.9B | 2.0x | 8.7x | |
| $5.9B | 3.1x | 12.0x | |
| $5.4B | 1.7x | 7.2x | |
| $5.4B | n/a | n/a | |
| $5.3B | 11.3x | 35.9x | |
| $5.2B | 1.9x | 5.1x | |
| $5.2B | 15.2x | -74.1x | |
| $5.2B | 6.3x | 28.9x | |
| $5.2B | 9.0x | 27.3x | |
| $4.9B | 5.2x | 13.7x | |
| $4.9B | 5.9x | 20.7x | |
| $4.8B | 10.9x | 34.5x | |
| $4.6B | 2768.8x | -16.7x | |
| $4.4B | 3.1x | 11.4x | |
| $4.2B | 8.5x | 22.4x | |
| $4.2B | 1.7x | 9.2x | |
| $4.2B | n/a | n/a | |
| $3.9B | 2.7x | 10.2x | |
| $3.9B | 3.7x | 17.2x | |
| $3.8B | 34.0x | -729.2x | |
| $3.8B | 12.0x | 75.3x | |
| $3.8B | n/a | n/a | |
| $3.7B | 7.5x | 16.8x | |
| $3.7B | 2.2x | 10.8x | |
| $3.6B | 5.4x | 14.9x | |
| $3.6B | 5.3x | 18.9x | |
| $3.6B | 4.3x | 15.5x | |
| $3.5B | 104.2x | n/a | |
| $3.5B | n/a | n/a | |
| $3.4B | 63.3x | -2593.6x | |
| $3.4B | 5.0x | n/a | |
| $3.3B | 35.6x | -30.1x | |
| $3.2B | n/a | -20.7x | |
| $3.2B | 1.5x | 10.2x | |
| $3.2B | 7.2x | -73.0x | |
| $3.1B | 2.5x | 11.8x | |
| $3.1B | 2.2x | 8.3x | |
| $3.0B | 9.1x | -140.1x | |
| $2.9B | 4.3x | 12.6x | |
| $2.9B | 14.2x | -62.0x | |
| $2.8B | 7.1x | 21.3x | |
| $2.8B | 23.9x | -108.1x | |
| $2.8B | n/a | n/a | |
| $2.7B | n/a | -13.9x | |
| $2.7B | 4.2x | 10.3x | |
| $2.7B | 4.3x | 12.0x | |
| $2.6B | 2458.7x | -7.1x | |
| $2.6B | 15.1x | 25.3x | |
| $2.6B | 3.7x | 19.3x | |
| $2.6B | 6.6x | -34.9x | |
| $2.5B | n/a | -11.6x | |
| $2.5B | 3.1x | 11.9x | |
| $2.5B | 13.1x | 38.4x | |
| $2.5B | 3.0x | 14.7x | |
| $2.5B | 3.9x | 29.6x | |
| $2.4B | 16.2x | n/a | |
| $2.4B | 6.4x | 17.9x | |
| $2.3B | 3.0x | 18.9x | |
| $2.2B | 3.8x | 17.0x | |
| $2.2B | n/a | -8.8x | |
| $2.1B | 9.8x | -64.1x | |
| $2.1B | 6.7x | 17.2x | |
| $2.1B | 5.3x | 14.7x | |
| $1.8B | 4.1x | n/a | |
| $1.8B | 6.9x | 57.4x | |
| $1.8B | 6.5x | 43.7x | |
| $1.8B | 7.3x | -4.7x | |
| $1.7B | 23289.2x | -8.3x | |
| $1.7B | 2.4x | 4.0x | |
| $1.7B | 3.9x | 15.0x | |
| $1.7B | n/a | n/a | |
| $1.7B | 11.4x | 27.8x | |
| $1.7B | 5.6x | 10.7x | |
| $1.6B | 0.7x | 4.3x | |
| $1.6B | n/a | n/a | |
| $1.6B | 2.2x | 6.1x | |
| $1.6B | 2.4x | 10.9x | |
| $1.6B | 5.9x | 23.2x | |
| $1.5B | n/a | n/a | |
| $1.5B | 25.2x | 51.9x | |
| $1.5B | 16.5x | n/a | |
| $1.5B | 5.7x | n/a | |
| $1.5B | 7.7x | 25.1x | |
| $1.4B | n/a | n/a | |
| $1.4B | 3.6x | -289.1x | |
| $1.4B | n/a | n/a | |
| $1.4B | 55.6x | -13.0x | |
| $1.4B | 12.9x | 351.6x | |
| $1.4B | 51.9x | -11.6x | |
| $1.3B | 6.0x | 25.1x | |
| $1.3B | n/a | -15.8x | |
| $1.3B | 0.6x | 6.4x | |
| $1.3B | 2.7x | 15.2x | |
| $1.3B | 21.7x | -7.0x | |
| $1.2B | n/a | -8.6x | |
| $1.2B | 43.2x | n/a | |
| $1.2B | 10.9x | 38.8x | |
| $1.2B | n/a | -6.6x | |
| $1.2B | 1.2x | 5.1x | |
| $1.2B | 2.1x | -96.4x | |
| $1.2B | 32.9x | -6.2x | |
| $1.2B | 7.3x | -577.4x | |
| $1.2B | n/a | -5.7x | |
| $1.2B | 3.1x | 14.0x | |
| $1.2B | 7.9x | 23.9x | |
| $1.2B | 9.1x | -23.8x | |
| $1.1B | n/a | n/a | |
| $1.1B | 374.3x | n/a | |
| $1.1B | 2.9x | n/a | |
| $1.1B | 1.3x | 5.4x | |
| $1.1B | 2.8x | 3.3x | |
| $1.1B | 6.8x | -6.7x | |
| $1.0B | 1.7x | -7.5x | |
| $999M | n/a | -6.8x | |
| $991M | n/a | -8.1x | |
| $986M | n/a | n/a | |
| $975M | n/a | n/a | |
| $961M | 394.9x | -6.6x | |
| $925M | 947.5x | -9.5x | |
| $913M | n/a | -8.2x | |
| $913M | 16.1x | n/a | |
| $904M | 2.5x | 51.9x | |
| $904M | 2.7x | 43.1x | |
| $897M | 148882.4x | -7.5x | |
| $876M | 7.6x | -7.5x | |
| $870M | 7.4x | 27.4x | |
| $867M | 2.7x | 66.5x | |
| $865M | n/a | n/a | |
| $827M | 1.4x | 6.8x | |
| $818M | 2.8x | 6.7x | |
| $810M | 61.7x | n/a | |
| $758M | n/a | -7.5x | |
| $745M | 16.4x | 133.6x | |
| $744M | n/a | n/a | |
| $739M | n/a | n/a | |
| $730M | n/a | n/a | |
| $717M | n/a | n/a | |
| $714M | 6.8x | 25.0x | |
| $713M | 4.8x | -2.5x | |
| $708M | 1.6x | 7.8x | |
| $650M | 2.4x | 10.9x | |
| $650M | n/a | n/a | |
| $638M | n/a | n/a | |
| $637M | 58.5x | -8.5x | |
| $620M | n/a | n/a | |
| $618M | 4.7x | -3.4x | |
| $591M | 7.8x | -7.3x | |
| $588M | 29.7x | -184.6x | |
| $573M | 3.3x | 17.1x | |
| $572M | 45.9x | -1.8x | |
| $563M | 26.4x | n/a | |
| $554M | n/a | -4.4x | |
| $540M | 46.8x | -3.6x | |
| $509M | 183.6x | -25.9x | |
| $509M | 20398.2x | n/a | |
| $506M | n/a | n/a | |
| $505M | 49.8x | -3.9x | |
| $502M | 2.2x | n/a | |
| $493M | 5.1x | 14.1x | |
| $489M | 35.1x | 67.4x | |
| $480M | 1.4x | 5.5x | |
| $478M | n/a | -3.6x | |
| $440M | 2.4x | 10.1x | |
| $438M | n/a | -3.2x | |
| $429M | 6.5x | -18.2x | |
| $428M | n/a | n/a | |
| $424M | n/a | -2.9x | |
| $412M | 10.8x | -4.3x | |
| $411M | 3.7x | 8.7x | |
| $410M | 15.6x | -8.1x | |
| $409M | 1.1x | 8.1x | |
| $406M | 1.4x | 10.3x | |
| $399M | 1.9x | -4.6x | |
| $398M | 3.3x | 63.2x | |
| $393M | 6.7x | 27.9x | |
| $366M | 25.8x | -8.4x | |
| $344M | 1.9x | 8.0x | |
| $332M | 0.8x | 8.0x | |
| $327M | 16.6x | -1116.9x | |
| $316M | 4.6x | 25.2x | |
| $315M | n/a | n/a | |
| $315M | 57.7x | -8.6x | |
| $308M | n/a | n/a | |
| $299M | 2.1x | -1.9x | |
| $290M | n/a | n/a | |
| $283M | n/a | n/a | |
| $277M | 6.9x | -30.6x | |
| $273M | 33.1x | -8.5x | |
| $254M | 65.9x | -1.1x | |
| $251M | n/a | n/a | |
| $248M | 49.7x | -1.0x | |
| $248M | n/a | -32.0x | |
| $247M | 10.5x | -141.6x | |
| $240M | 5.0x | 21.2x | |
| $230M | 5.2x | 16.5x | |
| $225M | 3.5x | 7.7x | |
| $225M | n/a | n/a | |
| $221M | n/a | -1.4x | |
| $217M | 5.6x | n/a | |
| $216M | n/a | n/a | |
| $208M | n/a | n/a | |
| $203M | 9.1x | -4.7x | |
| $195M | n/a | n/a | |
| $194M | 2.4x | -8.4x | |
| $194M | 1.6x | 16.7x | |
| $191M | n/a | n/a | |
| $190M | 21310.2x | -2.0x | |
| $190M | 2.8x | n/a | |
| $189M | 6.7x | n/a | |
| $187M | 96.2x | -5.8x | |
| $186M | 51.1x | -4.2x | |
| $182M | 1257.3x | n/a | |
| $175M | 13.9x | -8.0x | |
| $169M | n/a | -12.1x | |
| $168M | 30.3x | -13.0x | |
| $167M | n/a | n/a | |
| $163M | 2.7x | n/a | |
| $154M | 6.8x | -4.0x | |
| $150M | n/a | -0.7x | |
| $146M | 2.6x | 99.6x | |
| $146M | 11.5x | -3.5x | |
| $141M | 31.3x | -10.0x | |
| $140M | 8.0x | -2.8x | |
| $138M | 391.1x | n/a | |
| $136M | n/a | n/a | |
| $134M | 37.0x | -1.9x | |
| $132M | n/a | -9.6x | |
| $126M | n/a | -1.4x | |
| $123M | 103.4x | -25.4x | |
| $121M | n/a | n/a | |
| $121M | n/a | n/a | |
| $119M | 30.8x | -0.9x | |
| $119M | n/a | n/a | |
| $111M | 1.6x | 10.1x | |
| $107M | n/a | n/a | |
| $106M | n/a | n/a | |
| $101M | n/a | n/a | |
| $101M | 6.7x | 23.1x | |
| $95.6M | n/a | n/a | |
| $93.6M | 1.1x | -3.3x | |
| $92.0M | n/a | n/a | |
| $88.1M | 8.1x | -57.7x | |
| $84.5M | n/a | n/a | |
| $83.6M | n/a | -1.6x | |
| $83.3M | 0.8x | -1.2x | |
| $79.7M | 9.7x | -2.7x | |
| $79.4M | 3.1x | 12.4x | |
| $75.9M | 17.8x | -5.6x | |
| $74.6M | 1203.4x | n/a | |
| $70.0M | n/a | n/a | |
| $67.0M | n/a | n/a | |
| $64.6M | n/a | n/a | |
| $64.6M | n/a | n/a | |
| $64.0M | n/a | n/a | |
| $63.0M | 2.1x | -0.8x | |
| $59.6M | 7.1x | -8.0x | |
| $58.9M | 0.3x | -1.1x | |
| $58.6M | n/a | n/a | |
| $57.9M | n/a | n/a | |
| $54.9M | n/a | n/a | |
| $54.8M | n/a | n/a | |
| $54.8M | 5.9x | 2.9x | |
| $54.7M | n/a | n/a | |
| $51.9M | 20.2x | -1.1x | |
| $51.7M | 26.3x | -147.7x | |
| $48.6M | n/a | n/a | |
| $47.3M | 9.6x | n/a | |
| $46.9M | 48.8x | -4.9x | |
| $44.4M | 11.7x | n/a | |
| $44.3M | 40.4x | -4.7x | |
| $44.1M | n/a | -2.4x | |
| $43.3M | 1.7x | 11.9x | |
| $42.0M | 6.1x | n/a | |
| $41.0M | 10.8x | n/a | |
| $38.4M | 4.9x | 173.8x | |
| $37.9M | 70.0x | -3.0x | |
| $36.8M | n/a | n/a | |
| $36.3M | n/a | n/a | |
| $34.2M | 1.9x | 43.0x | |
| $33.7M | n/a | n/a | |
| $33.4M | n/a | n/a | |
| $32.2M | n/a | n/a | |
| $30.7M | 29.7x | -7.9x | |
| $29.8M | n/a | n/a | |
| $28.2M | n/a | -15.4x | |
| $27.9M | n/a | n/a | |
| $27.5M | 1.3x | -0.1x | |
| $26.1M | n/a | n/a | |
| $26.0M | n/a | -6.2x | |
| $25.9M | n/a | n/a | |
| $25.5M | n/a | -5.3x | |
| $25.5M | n/a | n/a | |
| $25.3M | 8.0x | -6.0x | |
| $24.1M | 0.4x | -0.1x | |
| $23.1M | 11.8x | 1857.4x | |
| $22.8M | n/a | n/a | |
| $22.3M | 15.0x | -0.3x | |
| $21.7M | n/a | n/a | |
| $21.7M | n/a | n/a | |
| $20.1M | n/a | n/a | |
| $19.9M | n/a | n/a | |
| $19.7M | n/a | n/a | |
| $19.5M | 2.8x | 8.1x | |
| $18.9M | 2.6x | -0.9x | |
| $17.0M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $15.6M | n/a | -3.8x | |
| $15.5M | n/a | n/a | |
| $15.3M | n/a | n/a | |
| $15.2M | n/a | n/a | |
| $15.1M | 6.8x | -1.9x | |
| $15.1M | n/a | n/a | |
| $14.9M | n/a | -3.2x | |
| $14.7M | n/a | n/a | |
| $14.4M | n/a | n/a | |
| $14.1M | 3.3x | -3.1x | |
| $14.1M | 9.8x | -34.4x | |
| $13.8M | 0.7x | -5.6x | |
| $13.5M | n/a | n/a | |
| $13.0M | 12.0x | -5.2x | |
| $13.0M | n/a | n/a | |
| $12.7M | 75.9x | -5.6x | |
| $12.7M | 4.0x | -4.4x | |
| $12.6M | 16.0x | -1.0x | |
| $12.4M | n/a | n/a | |
| $12.0M | n/a | n/a | |
| $10.8M | n/a | n/a | |
| $10.4M | n/a | n/a | |
| $10.4M | n/a | n/a | |
| $10.2M | n/a | n/a | |
| $10.1M | n/a | -4.9x | |
| $9.6M | n/a | n/a | |
| $9.1M | n/a | n/a | |
| $9.1M | 7.6x | -0.7x | |
| $9.0M | 4.9x | -0.6x | |
| $8.7M | 9.6x | -10.9x | |
| $8.4M | n/a | n/a | |
| $7.9M | 5.1x | -0.2x | |
| $7.7M | n/a | -12.1x | |
| $6.9M | n/a | -1.2x | |
| $6.9M | n/a | n/a | |
| $6.7M | n/a | n/a | |
| $6.5M | n/a | -6.8x | |
| $6.1M | 12.3x | n/a | |
| $5.7M | n/a | n/a | |
| $5.5M | 44.1x | -1.8x | |
| $5.4M | n/a | n/a | |
| $5.3M | 0.7x | -3.3x | |
| $5.2M | n/a | n/a | |
| $4.8M | n/a | -1.3x | |
| $4.8M | 25.3x | -1.5x | |
| $4.4M | n/a | n/a | |
| $4.4M | n/a | -2.5x | |
| $4.2M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $3.6M | n/a | n/a | |
| $3.6M | n/a | n/a | |
| $3.1M | n/a | n/a | |
| $3.0M | n/a | n/a | |
| $3.0M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.3M | n/a | n/a | |
| $2.2M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.5M | n/a | n/a | |
| $1.5M | n/a | 0.3x | |
| $1.5M | n/a | n/a | |
| $1.2M | 1.4x | n/a | |
| $1.0M | 2.5x | -0.1x | |
| $0.8M | n/a | n/a | |
| $0.6M | n/a | n/a | |
| $0.5M | n/a | n/a | |
| $0.3M | n/a | n/a | |
| $0.2M | n/a | n/a | |
| $0.2M | 0.0x | -0.0x | |
| $0.1M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.3M | n/a | n/a | |
| -$0.4M | n/a | n/a | |
| -$4.5M | n/a | n/a | |
| -$5.5M | n/a | n/a | |
| -$7.4M | n/a | 0.9x | |
| -$22.2M | -5.1x | 0.3x | |
| -$27.3M | -11.7x | n/a | |
| -$101M | -41.7x | 0.5x | |
| -$122M | -4.0x | 0.7x | |
| -$1.5B | -4.6x | 6.1x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals